Current Liabilities
Accrued Litigation
AbbVie Accrued Litigation decreased by 16.7% to $1.50B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 37.5%, from $2.40B to $1.50B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2023
Last reportedQ3 2025
How to read this metric
An increase suggests heightened legal risk or the emergence of new regulatory challenges, which may impact future profitability.
Detailed definition
This represents the estimated financial liability for ongoing legal proceedings or regulatory disputes. It reflects mana...
Peer comparison
Varies significantly based on the regulatory environment and the litigious nature of the industry.
Metric ID:
accrued_litigationHistorical Data
6 periods
| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $2.00B | $2.40B | $2.50B | $1.80B | $1.80B | $1.50B |
| QoQ Change | — | +20.0% | +4.2% | -28.0% | +0.0% | -16.7% |
| YoY Change | — | — | +25.0% | — | — | -37.5% |
Range$1.50B – $2.50B
CAGR-20.6%
Avg YoY Growth-6.3%
Median YoY Growth-6.3%
Accrued Litigation at Other Companies
Frequently Asked Questions
- What is AbbVie's accrued litigation?
- AbbVie (ABBV) reported accrued litigation of $1.50B in Q3 2025.
- How has AbbVie's accrued litigation changed year-over-year?
- AbbVie's accrued litigation decreased by 37.5% year-over-year, from $2.40B to $1.50B.
- What does accrued litigation mean?
- Money set aside to cover potential costs from legal or regulatory disputes.